Raising Public Awareness for Rare Diseases

LSC News

On February 26, LSC was fortunate to commemorate Rare Disease Day by spending the afternoon with people, families and caregivers living with Angelman syndrome and Fragile X syndrome.

Rare Disease Day, which is celebrated annually across the globe on the last day of February, is a special awareness day dedicated to elevating the public understanding of rare diseases, calling attention to the special challenges impacted people face and an opportunity to reinforce the importance of science and research in developing new medicines and advancing understanding of rare diseases.

Motivated by a passion to support advocacy, we partnered with Ovid Therapeutics Inc. (a NYC-based biopharmaceutical company focused on developing medicines for rare neurologic disorders) to host an event bringing together the Angelman syndrome and Fragile X syndrome communities to show our support and let them know that they are not alone. By bringing more attention to the many unique needs of the rare disease community, the event was also a chance to draw attention to the research and policies needed to advance understanding of these disorders that challenge the lives of so many, reinforcing this year’s theme, “with research, possibilities are limitless.”

According to the National Institutes of Health (NIH) in the U.S., a disease is rare if it affects fewer than 200,000 people. Quick facts about rare diseases:

  • It is estimated that 350 million people worldwide suffer from rare diseases.
  • There are approximately 7,000 different types of rare diseases and disorders, with more being discovered each day.
  • 30 million people in the U.S. are living with rare diseases. This equates to 1 in 10 Americans or 10% of the U.S. population.
  • If all of the people with rare diseases lived in one country, it would be the world’s 3rd most populous country.
  • 80 percent of rare diseases are genetic in origin, and thus are present throughout a person’s life, even if symptoms do not immediately appear.

More News